Vincent Launay‐Vacher

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

Vincent Launay‐Vacher, Stéphane Oudard, Nicolas Janus et al. · Cancer · 2007 · 455 citations

Pharmacy, Oncology, Pharmacotherapy +17

Cancer and renal insufficiency results of the BIRMA study

Nicolas Janus, Vincent Launay‐Vacher, E. Byloos et al. · British Journal of Cancer · 2010 · 194 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study

Hassane Izzedine, Jean‐Sébastien Hulot, Daniel Vittecoq et al. · Nephrology Dialysis Transplantation · 2005 · 182 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Renal safety of tenofovir in HIV treatment-experienced patients

Hassane Izzedine, Corinne Isnard Bagnis, Jean‐Sébastien Hulot et al. · AIDS · 2004 · 174 citations

Medicine, Nephrology, Pharmacotherapy +17

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies

Hassane Izzedine, Jean‐Sébastien Hulot, Vincent Launay‐Vacher et al. · Kidney International · 2004 · 160 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17